UA96948C2 - Вакцина, которая содержит бактерии, которые являются возбудителем верхних дыхательных путей и половых путей цыплят - Google Patents

Вакцина, которая содержит бактерии, которые являются возбудителем верхних дыхательных путей и половых путей цыплят

Info

Publication number
UA96948C2
UA96948C2 UAA200900431A UAA200900431A UA96948C2 UA 96948 C2 UA96948 C2 UA 96948C2 UA A200900431 A UAA200900431 A UA A200900431A UA A200900431 A UAA200900431 A UA A200900431A UA 96948 C2 UA96948 C2 UA 96948C2
Authority
UA
Ukraine
Prior art keywords
negative
positive
chicken
disease
vaccine composition
Prior art date
Application number
UAA200900431A
Other languages
English (en)
Ukrainian (uk)
Inventor
Мария Елена Вазкез
Рауль КАМПОГАРРИДО
Карлос Гонзалес-Эрнандес
Вайсинасан Сиванандан
Original Assignee
Берингер Ингельхайм Ветмедика С.А. Де Ц.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Берингер Ингельхайм Ветмедика С.А. Де Ц.В. filed Critical Берингер Ингельхайм Ветмедика С.А. Де Ц.В.
Publication of UA96948C2 publication Critical patent/UA96948C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
UAA200900431A 2001-10-26 2002-10-24 Вакцина, которая содержит бактерии, которые являются возбудителем верхних дыхательных путей и половых путей цыплят UA96948C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10152307A DE10152307A1 (de) 2001-10-26 2001-10-26 Neue bakterielle Geflügelkrankheit

Publications (1)

Publication Number Publication Date
UA96948C2 true UA96948C2 (ru) 2011-12-26

Family

ID=7703460

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA200900431A UA96948C2 (ru) 2001-10-26 2002-10-24 Вакцина, которая содержит бактерии, которые являются возбудителем верхних дыхательных путей и половых путей цыплят
UA20040503962A UA89607C2 (ru) 2001-10-26 2002-10-24 Штамм бактерий, который является возбудителем заболевания верхних дыхательных и половых путей циплят, и вакцина, которая его содержит

Family Applications After (1)

Application Number Title Priority Date Filing Date
UA20040503962A UA89607C2 (ru) 2001-10-26 2002-10-24 Штамм бактерий, который является возбудителем заболевания верхних дыхательных и половых путей циплят, и вакцина, которая его содержит

Country Status (32)

Country Link
US (3) US7794735B2 (ru)
EP (2) EP1442114B1 (ru)
JP (2) JP4447319B2 (ru)
KR (2) KR101024887B1 (ru)
CN (1) CN100471945C (ru)
AR (3) AR037020A1 (ru)
AT (1) ATE391767T1 (ru)
AU (1) AU2002363173B2 (ru)
BR (1) BR0213538A (ru)
CA (1) CA2462652A1 (ru)
CO (1) CO5580796A2 (ru)
CY (1) CY1108178T1 (ru)
DE (2) DE10152307A1 (ru)
DK (1) DK1442114T3 (ru)
EC (1) ECSP045083A (ru)
ES (1) ES2304466T3 (ru)
HK (1) HK1073862A1 (ru)
HR (1) HRP20040366B1 (ru)
HU (1) HU228692B1 (ru)
IL (1) IL161223A0 (ru)
MA (1) MA26293A1 (ru)
MX (1) MXPA04003941A (ru)
MY (1) MY138203A (ru)
NO (1) NO333635B1 (ru)
NZ (1) NZ532805A (ru)
PL (1) PL206589B1 (ru)
PT (1) PT1442114E (ru)
RU (4) RU2334792C2 (ru)
SI (1) SI1442114T1 (ru)
UA (2) UA96948C2 (ru)
WO (1) WO2003037367A2 (ru)
ZA (1) ZA200402499B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10152307A1 (de) * 2001-10-26 2003-05-08 Boehringer Ingelheim Vetmed Neue bakterielle Geflügelkrankheit
JP2013507103A (ja) * 2009-10-09 2013-03-04 ケベンハウンス ウニヴェルジテート（ユニバーシティ オブ コペンハーゲン） Ｇａｌｌｉｂａｃｔｅｒｉｕｍａｎａｔｉｓ由来の細胞溶解性ＲＴＸ毒素
CN102380092A (zh) * 2011-11-22 2012-03-21 青岛易邦生物工程有限公司 一种鸡传染性鼻炎灭活疫苗
CN102406936A (zh) * 2011-11-22 2012-04-11 青岛易邦生物工程有限公司 一种鸡传染性鼻炎灭活疫苗佐剂
HUE048344T2 (hu) 2013-03-18 2020-08-28 Intervet Int Bv Vakcina kérõdzõ védelmére Mannheimia haemolytica okozta tüdõgyulladás ellen
RU2563885C1 (ru) * 2014-06-03 2015-09-27 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) Способ определения антител к бактериальным антигенам
CN104491856A (zh) * 2014-12-07 2015-04-08 青岛易邦生物工程有限公司 一种禽肺病毒病灭活疫苗的生产方法
CN108728558A (zh) * 2018-05-31 2018-11-02 广西壮族自治区兽医研究所 一种快速检测溶血性曼氏杆菌的pcr扩增引物及其应用
CN111621450B (zh) * 2020-07-10 2022-07-05 青岛易邦生物工程有限公司 一种鸭源鸡杆菌及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5855894A (en) * 1992-03-30 1999-01-05 Pfizer Inc. Pasteurella haemolytica type A-1 bacterin-toxoid vaccine
US5576003A (en) 1992-10-14 1996-11-19 Akzo Nobel N.V. Ornithobacterium rhinotracheale vaccine and method of immunization
US5587305A (en) 1993-12-06 1996-12-24 The United States Of America As Represented By The Department Of Agriculture Pasteurella haemolytica transformants
RU94023126A (ru) * 1994-06-16 1997-04-10 Всероссийский научно-исследовательский институт экспериментальной ветеринарии им.Я.Р.Коваленко Вакцина против пастереллеза свиней
RU2103355C1 (ru) * 1995-11-23 1998-01-27 Государственное Федеральное предприятие Государственный научный центр прикладной микробиологии Способ получения аттенуированных иммуногенных штаммов pasteurella multocida
FR2760640B1 (fr) * 1997-03-17 1999-05-28 Vetoquinol Sa Utilisation d'une souche de pasteurella haemolytica serotype a6 pour la preparation d'un vaccin contre la pasteurellose bovine due a pasteurella haemolytica
US7304151B2 (en) * 1999-12-17 2007-12-04 University Of Guelph Modified leukotoxin gene and protein
US7521060B2 (en) 2001-10-26 2009-04-21 Boehringer Ingelheim Vetmedica S.A. De C.V. Pathogen for bacterial poultry disease
DE10152307A1 (de) 2001-10-26 2003-05-08 Boehringer Ingelheim Vetmed Neue bakterielle Geflügelkrankheit

Also Published As

Publication number Publication date
US7964197B2 (en) 2011-06-21
AR073482A2 (es) 2010-11-10
IL161223A0 (en) 2004-09-27
US20090181055A1 (en) 2009-07-16
CY1108178T1 (el) 2014-02-12
HUP0402098A2 (hu) 2005-02-28
NZ532805A (en) 2008-04-30
CO5580796A2 (es) 2005-11-30
PT1442114E (pt) 2008-05-20
KR20050039688A (ko) 2005-04-29
RU2430967C2 (ru) 2011-10-10
PL369963A1 (en) 2005-05-02
SI1442114T1 (sl) 2008-08-31
AR067732A2 (es) 2009-10-21
WO2003037367A2 (en) 2003-05-08
CN1575334A (zh) 2005-02-02
KR101024887B1 (ko) 2011-03-31
EP1442114A2 (en) 2004-08-04
NO333635B1 (no) 2013-07-29
MA26293A1 (fr) 2004-09-01
RU2007148219A (ru) 2009-07-10
ECSP045083A (es) 2004-08-27
HU228692B1 (en) 2013-05-28
KR100954175B1 (ko) 2010-04-20
DK1442114T3 (da) 2008-06-09
US7794735B2 (en) 2010-09-14
WO2003037367A3 (en) 2003-10-09
KR20090083941A (ko) 2009-08-04
RU2004116134A (ru) 2005-05-10
ZA200402499B (en) 2005-06-08
DE60226057T2 (de) 2009-05-14
NO20041675L (no) 2004-04-23
DE60226057D1 (de) 2008-05-21
US20110212132A1 (en) 2011-09-01
RU2007129099A (ru) 2009-02-10
CA2462652A1 (en) 2003-05-08
DE10152307A1 (de) 2003-05-08
RU2334792C2 (ru) 2008-09-27
PL206589B1 (pl) 2010-08-31
RU2481393C2 (ru) 2013-05-10
JP4447319B2 (ja) 2010-04-07
HRP20040366B1 (en) 2012-05-31
JP2005511032A (ja) 2005-04-28
AU2002363173B2 (en) 2007-09-20
RU2008136404A (ru) 2010-03-20
ATE391767T1 (de) 2008-04-15
ES2304466T3 (es) 2008-10-16
MY138203A (en) 2009-05-29
HK1073862A1 (en) 2005-10-21
EP1442114B1 (en) 2008-04-09
CN100471945C (zh) 2009-03-25
MXPA04003941A (es) 2004-11-29
UA89607C2 (ru) 2010-02-25
HUP0402098A3 (en) 2005-07-28
EP1942181A1 (en) 2008-07-09
US20100104594A1 (en) 2010-04-29
AR037020A1 (es) 2004-10-20
JP5087604B2 (ja) 2012-12-05
BR0213538A (pt) 2004-10-19
HRP20040366A2 (en) 2005-04-30
JP2010051324A (ja) 2010-03-11
RU2456343C2 (ru) 2012-07-20

Similar Documents

Publication Publication Date Title
HUP0100623A2 (hu) Eljárások bakteriális burok-poliszacharidok extrakciójára és izolálására, azok vakcinaként vagy fehérjékhez kapcsoltan konjugátum-vakcinaként történő alkalmazására
HUP0203056A1 (hu) Vakcinakészítmény
FR10C0043I1 (fr) Solubilisation de polysaccharides capsulaires
GB2322801B (en) Vaccine compositions for intranasal administration comprising chitosan and use thereof
HUP0200367A2 (en) Streptococcus vaccine
AU2001278003A1 (en) Bacteriophage having multiple host range
WO2002009746A3 (en) Vaccines comprising outer membrane vesciles from gram negative bacteria
UA96948C2 (ru) Вакцина, которая содержит бактерии, которые являются возбудителем верхних дыхательных путей и половых путей цыплят
WO2002010343A3 (en) Temperature-sensitive live vaccine for mycoplasma hyopneumoniae
DK1112747T3 (da) Salmonellavaccine, som ikke inducerer antistoffer mod flagellin eller flageller
HU9801705D0 (en) Streptococcus equi vaccine
DE10399019I1 (de) Gefluegelkrankheit verursachende neue Bakterie unddaraus stammender Impfstoff
DK0975360T3 (da) Bovint respiratorisk og enterisk coronavirus som vaccine
AU4791799A (en) Screening of neisserial vaccine candidates and vaccines against pathogenic neisseria
EP1430025A4 (en) METHOD AND COMPOSITIONS FOR TREATING OR PREVENTING BACTERIAL INFECTIONS
NZ295877A (en) A vaccine comprising the helicobacter bacterium and its use
AU6761301A (en) Adjuvant composition comprising fha protein or fragment of fha protein in free form